Drug recall D-1067-2019
Product
Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02
Reason for recall
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Lots and codes
Lot #: T97469, Exp. 7/2019, W28574, Exp.09/2019
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 67 cartons (25 vials per carton)
- Distribution
- Nationwide USA and Guam
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2019
- Terminated
- August 11, 2022
Related products
- Cleocin Phosphate – drug information
- NDC 0009-0775 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC
- NDC 0009-0902 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC
- NDC 0009-0870 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC